Impel Pharmaceuticals CEO Adrian Adams resigns; CCO Len Paolillo named interim CEO

IMPEL PHARMACEUTICALS INC

Adrian Adams resigned as Chairman, President and CEO effective Nov. 4, 2023; no disagreement cited.
Leonard S. Paolillo, current Chief Commercial Officer, appointed Interim President and CEO.
Paolillo joined Impel in March 2021; previously EVP & CCO at Kyowa Kirin North America.
Board to formally appoint Paolillo upon Adams's departure.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Adrian Adams

Chairman of the Board, President and Chief Executive Officer

IMPEL PHARMACEUTICALS INC

Effective: 2023-11-04
Successor: Leonard S. Paolillo
Filed: November 2, 2023, 7:59 PM ET

On October 29, 2023, Adrian Adams gave notice of his resignation from his position as Chairman of the Board and as President and Chief Executive Officer of Impel Pharmaceuticals Inc. (the “ Company ”) effective November 4, 2023.

Appointed (interim)

Leonard S. Paolillo

Interim President and Chief Executive Officer

IMPEL PHARMACEUTICALS INC

Effective: 2023-11-04
Filed: November 2, 2023, 7:59 PM ET

The Board of Directors of the Company intends to appoint Leonard S. Paolillo as Interim President and Chief Executive Officer effective upon Mr. Adams’s resignation.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Adrian Adams resigned as Chairman of the Board, President and Chief Executive Officer at IMPEL PHARMACEUTICALS INC.

Action: resigned
Role: Chairman of the Board, President and Chief Executive Officer

Exact text from the filing

On October 29, 2023, Adrian Adams gave notice of his resignation from his position as Chairman of the Board and as President and Chief Executive Officer of Impel Pharmaceuticals Inc. (the “ Company ”) effective November 4, 2023.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Leonard S. Paolillo was appointed as Interim President and Chief Executive Officer at IMPEL PHARMACEUTICALS INC.

Action: appointed
Role: Interim President and Chief Executive Officer

Exact text from the filing

The Board of Directors of the Company intends to appoint Leonard S. Paolillo as Interim President and Chief Executive Officer effective upon Mr. Adams’s resignation.

View on SEC.gov

Source: SEC EDGAR

accession 0001193125-23-269514

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.